Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
Neff GW, O'Brien CB, Cirocco R, Montalbano M, de Medina M, Ruiz P, Khaled AS, Bejarano PA, Safdar K, Hill MA, Tzakis AG, Schiff ER. Neff GW, et al. Among authors: cirocco r. Liver Transpl. 2004 May;10(5):595-8. doi: 10.1002/lt.20115. Liver Transpl. 2004. PMID: 15108250 Free article.
In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease.
Fragulidis GP, Cirocco RE, Weppler D, Berho M, Gillian G, Markou M, Viciana A, Esquenazi V, Nery JR, Miller J, Reddy KR, Tzakis AG. Fragulidis GP, et al. Among authors: cirocco re. Transplantation. 1998 Dec 15;66(11):1472-6. doi: 10.1097/00007890-199812150-00010. Transplantation. 1998. PMID: 9869088
Recurrent hepatitis C infection following orthotopic liver transplantation is predicted by posttransplant serum and hepatic allograft viral titers.
Cirocco R, Fragulidis GP, Weppler D, Zucker K, Markou M, Zervos XA, Viciana A, Esquinazi V, Nery JR, Reddy KR, Schiff E, Miller J, Tzakis AG. Cirocco R, et al. Transplant Proc. 1997 Nov;29(7):2839-40. doi: 10.1016/s0041-1345(97)00699-4. Transplant Proc. 1997. PMID: 9365583 Free article. No abstract available.
Early graft loss secondary to massive hemorrhagic necrosis following orthotopic liver transplantation. Evidence for cytokine-mediated univisceral Shwartzman reaction.
Burke GW, Cirocco R, Viciana A, Ruiz P, Markou M, Allouch M, Ciancio G, Reddy R, Jeffers L, Schiff E, Nery J, Miller J, Tzakis AG. Burke GW, et al. Among authors: cirocco r. Transplantation. 1996 May 15;61(9):1370-6. doi: 10.1097/00007890-199605150-00015. Transplantation. 1996. PMID: 8629299
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
Ciancio G, Burke GW, Gaynor JJ, Carreno MR, Cirocco RE, Mathew JM, Mattiazzi A, Cordovilla T, Roth D, Kupin W, Rosen A, Esquenazi V, Tzakis AG, Miller J. Ciancio G, et al. Among authors: cirocco re. Transplantation. 2005 Aug 27;80(4):457-65. doi: 10.1097/01.tp.0000165847.05787.08. Transplantation. 2005. PMID: 16123718 Clinical Trial.
Hepatitis C in liver transplantation: preliminary study of prognostic factors.
Nery J, Esquenazi V, Weppler D, Gomez C, Cirocco R, Gharagozloo H, Zucker K, Reddy R, Casella J, Parker I, Faria W, Jeffers L, Carreno M, Smith J, Markow M, Allouch M, Babischkin S, Bourke G, Hill M, Schiff E, LaRue S, Miller J. Nery J, et al. Among authors: cirocco r. Transpl Int. 1994;7 Suppl 1:S229-31. doi: 10.1111/j.1432-2277.1994.tb01354.x. Transpl Int. 1994. PMID: 11271211
61 results